Ho B - Search Results

1

⁶⁸ Ga-PSMA-PET/CT staging prior to definitive radiation treatment for prostate cancer.

Hruby G, Eade T, Emmett L, Ho B, Hsiao E, Schembri G, Guo L, Kwong C, Hunter J, Byrne K, Kneebone A. Hruby G, et al. Among authors: ho b. Asia Pac J Clin Oncol. 2018 Aug;14(4):343-346. doi: 10.1111/ajco.12872. Epub 2018 Apr 16. Asia Pac J Clin Oncol. 2018. PMID: 29663686

2

Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.

Morigi JJ, Stricker PD, van Leeuwen PJ, Tang R, Ho B, Nguyen Q, Hruby G, Fogarty G, Jagavkar R, Kneebone A, Hickey A, Fanti S, Tarlinton L, Emmett L. Morigi JJ, et al. Among authors: ho b. J Nucl Med. 2015 Aug;56(8):1185-90. doi: 10.2967/jnumed.115.160382. Epub 2015 Jun 25. J Nucl Med. 2015. PMID: 26112024 Free article.

3

(68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.

van Leeuwen PJ, Stricker P, Hruby G, Kneebone A, Ting F, Thompson B, Nguyen Q, Ho B, Emmett L. van Leeuwen PJ, et al. Among authors: ho b. BJU Int. 2016 May;117(5):732-9. doi: 10.1111/bju.13397. Epub 2016 Jan 24. BJU Int. 2016. PMID: 26683282

4

Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.

van Leeuwen PJ, Emmett L, Ho B, Delprado W, Ting F, Nguyen Q, Stricker PD. van Leeuwen PJ, et al. Among authors: ho b. BJU Int. 2017 Feb;119(2):209-215. doi: 10.1111/bju.13540. Epub 2016 Jun 18. BJU Int. 2017. PMID: 27207581

5

SPECT-CT/VQ versus CTPA for diagnosing pulmonary embolus and other lung pathology: Pre-existing lung disease should not be a contraindication.

Bhatia KD, Ambati C, Dhaliwal R, Paschkewitz R, Hsu E, Ho B, Young A, Emmett L. Bhatia KD, et al. Among authors: ho b. J Med Imaging Radiat Oncol. 2016 Aug;60(4):492-7. doi: 10.1111/1754-9485.12471. Epub 2016 May 11. J Med Imaging Radiat Oncol. 2016. PMID: 27461384

6

Delineating biochemical failure with ⁶⁸Ga-PSMA-PET following definitive external beam radiation treatment for prostate cancer.

Hruby G, Eade T, Kneebone A, Emmett L, Guo L, Ho B, Hsiao E, Schembri G, Hunter J, Kwong C. Hruby G, et al. Among authors: ho b. Radiother Oncol. 2017 Jan;122(1):99-102. doi: 10.1016/j.radonc.2016.11.023. Epub 2016 Dec 28. Radiother Oncol. 2017. PMID: 28040309

7

Frusemide aids diagnostic interpretation of ⁶⁸ Ga-PSMA positron emission tomography/CT in men with prostate cancer.

Fennessy N, Lee J, Shin J, Ho B, Ali SA, Paschkewitz R, Emmett L. Fennessy N, et al. Among authors: ho b. J Med Imaging Radiat Oncol. 2017 Dec;61(6):739-744. doi: 10.1111/1754-9485.12625. Epub 2017 Jun 17. J Med Imaging Radiat Oncol. 2017. PMID: 28623852

8

The Impact of ⁶⁸Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study.

Roach PJ, Francis R, Emmett L, Hsiao E, Kneebone A, Hruby G, Eade T, Nguyen QA, Thompson BD, Cusick T, McCarthy M, Tang C, Ho B, Stricker PD, Scott AM. Roach PJ, et al. Among authors: ho b. J Nucl Med. 2018 Jan;59(1):82-88. doi: 10.2967/jnumed.117.197160. Epub 2017 Jun 23. J Nucl Med. 2018. PMID: 28646014 Free article.

9

Treatment Outcomes from ⁶⁸Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET.

Emmett L, van Leeuwen PJ, Nandurkar R, Scheltema MJ, Cusick T, Hruby G, Kneebone A, Eade T, Fogarty G, Jagavkar R, Nguyen Q, Ho B, Joshua AM, Stricker P. Emmett L, et al. Among authors: ho b. J Nucl Med. 2017 Dec;58(12):1972-1976. doi: 10.2967/jnumed.117.196683. Epub 2017 Jul 26. J Nucl Med. 2017. PMID: 28747524 Free article.

10

Gallium-68-prostate-specific membrane antigen (⁶⁸ Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer.

van Leeuwen PJ, Donswijk M, Nandurkar R, Stricker P, Ho B, Heijmink S, Wit EMK, Tillier C, van Muilenkom E, Nguyen Q, van der Poel HG, Emmett L. van Leeuwen PJ, et al. Among authors: ho b. BJU Int. 2019 Jul;124(1):62-68. doi: 10.1111/bju.14506. Epub 2019 Apr 7. BJU Int. 2019. PMID: 30074667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,366 results

Search Page

Filters